Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 5.34
-0.06 (-1.11%)
Apr 28, 2026, 5:17 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €149.52 million as of April 28, 2026. Its market cap has decreased by -18.82% in one year.
Market Cap
149.52M
Enterprise Value
136.86M
Revenue
8.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.34
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 149.52M, a decrease of -38.90%. That is a compound annual growth rate of -8.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onward Medical | 200.59M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 13.52M |
| Financière de Tubize | 9.00B |
| BioSenic | 1.44M |
| argenx SE | 42.11B |
| UCB SA | 45.29B |
| Oxurion NV | 354.77K |